Natural and synthetic polymers as drug carriers for delivery of therapeutic proteins

Polymer Reviews

Volumn 55, Issue 3, 2015, Pages 371-406

  Hamid Akash, Muhammad Sajid ^a,b   Rehman, Kanwal ^a,c,d   Chen, Shuqing ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b UNIVERSITY OF FAISALABAD   (Pakistan)

^c ZHEJIANG UNIVERSITY   (China)

^d UNIVERSITY OF AGRICULTURE   (Pakistan)

Author keywords

Natural polymers; natural protein based polymers; polysaccharide based polymers; recombinant protein based polymers; synthetic polymers; therapeutic proteins

Indexed keywords

BIOCHEMISTRY; FUNCTIONAL POLYMERS; NATURAL POLYMERS; RECOMBINANT PROTEINS;

DRUG CARRIER SYSTEMS; ENZYMATIC DEGRADATION; MULTIPLE INJECTIONS; NATURAL PROTEINS; ORAL ADMINISTRATION; PROTEIN-BASED POLYMERS; SYNTHETIC POLYMERS; THERAPEUTIC PROTEIN;

PROTEINS;

EID: 84954025837     PISSN: 15583724     EISSN: 15583716     Source Type: Journal    
DOI: 10.1080/15583724.2014.995806     Document Type: Review

References (288)

1. Degim, I. T., Celebi, N. " Controlled delivery of peptides and proteins ", Curr. Pharm. Des. 2007, 13, 99-117.
2. Torchilin, V. " Intracellular delivery of protein and peptide therapeutics ", Drug Discovery Today: Technologies. 2008, 5, e95-e103.
3. Oak, M., Mandke, R., Layek, B., Sharma, G., Singh, J. " Controlled-Release Systems for Biologics ". In Pharmaceutical Sciences Encyclopedia: Drug Discovery, Development, and Manufacturing; Gad, S. C., ed., John Wiley & Sons, Inc., 2010, pp 1-22.
4. Oh, W.-K., Kwon, O. S., Jang, J. " Conducting polymer nanomaterials for biomedical applications: Cellular interfacing and biosensing ", Polym. Rev. 2013, 53, 407-442.
5. Francis, R., Joy, N., Aparna, E., Vijayan, R. " Polymer grafted inorganic nanoparticles, preparation, properties, and applications: A review ", Polym. Rev. 2014, 54, 268-347.
6. Sinha, V. R., Trehan, A. " Biodegradable microspheres for protein delivery ", J. Control. Release. 2003, 90, 261-280.
7. Bertrand, N., Leroux, J. C. " The journey of a drug-carrier in the body: an anatomo-physiological perspective ", J. Control. Release. 2012, 161, 152-163.
8. George, M., Abraham, T. E. " Polyionic hydrocolloids for the intestinal delivery of protein drugs: alginate and chitosan: A review ", J. Control. Release. 2006, 114, 1-14.
9. Dang, J. M., Leong, K. W. " Natural polymers for gene delivery and tissue engineering ", Adv. Drug Deliv. Rev. 2006, 58, 487-499.
10. Lu, R., Yoshida, T., Miyakoshi, T. " Oriental lacquer: A natural polymer ", Polym. Rev. 2013, 53, 153-191.
11. Liu, Z., Jiao, Y., Wang, Y., Zhou, C., Zhang, Z. " Polysaccharides-based nanoparticles as drug delivery systems ", Adv. Drug Deliv. Rev. 2008, 60, 1650-1662.
12. Sonam Chaudhary., Arora H., Kholi V., Kumar K., V. " Effect of physicochemical properties of biodegradable polymers on nano drug delivery ", Polym. Rev. 2013, 53, 546-567.
13. Zhang, N., Wardwell, P. R., Bader, R. A. " Polysaccharide-based micelles for drug delivery ", Pharmaceutics. 2013, 5, 329-352.
14. Lee, J. W., Park, J. H., Robinson, J. R. " Bioadhesive-based dosage forms: the next generation ", J. Pharm. Sci. 2000, 89, 850-866.
15. Smart, J. D. " The basics and underlying mechanisms of mucoadhesion ", Adv. Drug Deliv. Rev. 2005, 57, 1556-1568.
16. Chung, S. W., Hil-lal, T. A., Byun, Y. " Strategies for non-invasive delivery of biologics ", J. Drug Target. 2012, 20, 481-501.
17. Kean, T., Thanou, M. " Biodegradation, biodistribution and toxicity of chitosan ", Adv. Drug Deliv. Rev. 2010, 62, 3-11.
18. Thanou, M., Verhoef, J. C., Junginger, H. E. " Chitosan and its derivatives as intestinal absorption enhancers ", Adv. Drug Deliv. Rev. 2001, 50, S91-101.
19. Cano-Cebrian, M. J., Zornoza, T., Granero, L., Polache, A. " Intestinal absorption enhancement via the paracellular route by fatty acids, chitosans and others: A target for drug delivery ", Curr Drug Deliv. 2005, 2, 9-22.
20. Smith, J., Wood, E., Dornish, M. " Effect of chitosan on epithelial cell tight junctions ", Pharm. Res. 2004, 21, 43-49.
21. Bravo-Osuna, I., Vauthier, C., Farabollini, A., Palmieri, G. F., Ponchel, G. " Mucoadhesion mechanism of chitosan and thiolated chitosan-poly(isobutyl cyanoacrylate) core-shell nanoparticles ", Biomaterials. 2007, 28, 2233-2243.
22. Sandri, G., Bonferoni, M. C., Rossi, S., Ferrari, F., Gibin, S., Zambito, Y., Di Colo, G., Caramella, C. " Nanoparticles based on N-trimethylchitosan: Evaluation of absorption properties using in vitro (Caco-2 cells) and ex vivo (excised rat jejunum) models ", Eur. J. Pharm. Biopharm. 2007, 65, 68-77.
23. Lin, Y. H., Sonaje, K., Lin, K. M., Juang, J. H., Mi, F. L., Yang, H. W., Sung, H. W. " Multi-ion-crosslinked nanoparticles with pH-responsive characteristics for oral delivery of protein drugs ", J. Control. Release. 2008, 132, 141-149.
24. Sonaje, K., Chen, Y. J., Chen, H. L., Wey, S. P., Juang, J. H., Nguyen, H. N., Hsu, C. W., Lin, K. J., Sung, H. W. " Enteric-coated capsules filled with freeze-dried chitosan/poly(gamma-glutamic acid) nanoparticles for oral insulin delivery ", Biomaterials. 2010, 31, 3384-3394.
25. Zhang, Y., Wei, W., Lv, P., Wang, L., Ma, G. " Preparation and evaluation of alginate-chitosan microspheres for oral delivery of insulin ", Eur. J. Pharm. Biopharm. 2011, 77, 11-19.
26. Makhlof, A., Fujimoto, S., Tozuka, Y., Takeuchi, H. " In vitro and in vivo evaluation of WGA-carbopol modified liposomes as carriers for oral peptide delivery ", Eur. J. Pharm. Biopharm. 2011, 77, 216-224.
27. Sonaje, K., Lin, Y. H., Juang, J. H., Wey, S. P., Chen, C. T., Sung, H. W. " In vivo evaluation of safety and efficacy of self-assembled nanoparticles for oral insulin delivery ", Biomaterials. 2009, 30, 2329-2339.
28. Amidi, M., Mastrobattista, E., Jiskoot, W., Hennink, W. E. " Chitosan-based delivery systems for protein therapeutics and antigens ", Adv. Drug Deliv. Rev. 2010, 62, 59-82.
29. Mi, F. L., Wu, Y. Y., Lin, Y. H., Sonaje, K., Ho, Y. C., Chen, C. T., Juang, J. H., Sung, H. W. " Oral delivery of peptide drugs using nanoparticles self-assembled by poly(gamma-glutamic acid) and a chitosan derivative functionalized by trimethylation ", Bioconjug. Chem. 2008, 19, 1248-1255.
30. Yin, L., Ding, J., He, C., Cui, L., Tang, C., Yin, C. " Drug permeability and mucoadhesion properties of thiolated trimethyl chitosan nanoparticles in oral insulin delivery ", Biomaterials. 2009, 30, 5691-5700.
31. Paliwal, R., Paliwal, S. R., Agrawal, G. P., Vyas, S. P. " Chitosan nanoconstructs for improved oral delivery of low molecular weight heparin: In vitro and in vivo evaluation ", Int. J. Pharm. 2012, 422, 179-184.
32. Hamman, J. H., Stander, M., Kotze, A. F. " Effect of the degree of quaternisation of N-trimethyl chitosan chloride on absorption enhancement: In vivo evaluation in rat nasal epithelia ", Int. J. Pharm. 2002, 232, 235-242.
33. Di Colo, G., Burgalassi, S., Zambito, Y., Monti, D., Chetoni, P. " Effects of different N-trimethyl chitosans on in vitro/in vivo ofloxacin transcorneal permeation ", J. Pharm. Sci. 2004, 93, 2851-2862.
34. Lee, E., Lee, J., Jon, S. " A novel approach to oral delivery of insulin by conjugating with low molecular weight chitosan ", Bioconjug. Chem. 2010, 21, 1720-1723.
35. Chae, S. Y., Jang, M. K., Nah, J. W. " Influence of molecular weight on oral absorption of water soluble chitosans ", J. Control. Release. 2005, 102, 383-394.
36. Lee, E., Lee, J., Lee, I. H., Yu, M., Kim, H., Chae, S. Y., Jon, S. " Conjugated chitosan as a novel platform for oral delivery of paclitaxel ", J. Med. Chem. 2008, 51, 6442-6449.
37. Bernkop-Schnurch, A. " Thiomers: A new generation of mucoadhesive polymers ", Adv. Drug Deliv. Rev. 2005, 57, 1569-1582.
38. Dunnhaupt, S., Barthelmes, J., Hombach, J., Sakloetsakun, D., Arkhipova, V., Bernkop-Schnurch, A. " Distribution of thiolated mucoadhesive nanoparticles on intestinal mucosa ", Int. J. Pharm. 2011, 408, 191-199.
39. Sajeesh, S., Vauthier, C., Gueutin, C., Ponchel, G., Sharma, C. P. " Thiol functionalized polymethacrylic acid-based hydrogel microparticles for oral insulin delivery ", Acta Biomater. 2010, 6, 3072-3080.
40. Bernkop-Schnurch, A., Hornof, M., Guggi, D. " Thiolated chitosans ", Eur. J. Pharm. Biopharm. 2004, 57, 9-17.
41. Foger, F., Schmitz, T., Bernkop-Schnurch, A. " In vivo evaluation of an oral delivery system for P-gp substrates based on thiolated chitosan ", Biomaterials. 2006, 27, 4250-4255.
42. Bhattarai, N., Matsen, F. A., Zhang, M. " PEG-grafted chitosan as an injectable thermoreversible hydrogel ", Macromol. Biosci. 2005, 5, 107-111.
43. Bhattarai, N., Ramay, H. R., Gunn, J., Matsen, F. A., Zhang, M. " PEG-grafted chitosan as an injectable thermosensitive hydrogel for sustained protein release ", J. Control. Release. 2005, 103, 609-624.
44. Yoo, H. S. " Photo-cross-linkable and thermo-responsive hydrogels containing chitosan and Pluronic for sustained release of human growth hormone (hGH) ", J. Biomater. Sci. Polym. Ed. 2007, 18, 1429-1441.
45. Van Tomme, S. R., Hennink, W. E. " Biodegradable dextran hydrogels for protein delivery applications ", Expert Rev. Med. Devices. 2007, 4, 147-164.
46. Mehvar, R. " Dextrans for targeted and sustained delivery of therapeutic and imaging agents ", J. Control. Release. 2000, 69, 1-25.
47. Cadee, J. A., de Groot, C. J., Jiskoot, W., den Otter, W., Hennink, W. E. " Release of recombinant human interleukin-2 from dextran-based hydrogels ", J. Control. Release. 2002, 78, 1-13.
48. De Groot, C. J., Cadee, J. A., Koten, J. W., Hennink, W. E., Den Otter, W. " Therapeutic efficacy of IL-2-loaded hydrogels in a mouse tumor model ", Int. J. Cancer. 2002, 98, 134-140.
49. Sarmento, B., Ribeiro, A., Veiga, F., Ferreira, D. " Development and characterization of new insulin containing polysaccharide nanoparticles ", Colloids Surf. B Biointerfaces. 2006, 53, 193-202.
50. Tanna, S., Joan Taylor, M., Sahota, T. S., Sawicka, K. " Glucose-responsive UV polymerised dextran-concanavalin A acrylic derivatised mixtures for closed-loop insulin delivery ", Biomaterials. 2006, 27, 1586-1597.
51. Tanna, S., Sahota, T. S., Sawicka, K., Taylor, M. J. " The effect of degree of acrylic derivatisation on dextran and concanavalin A glucose-responsive materials for closed-loop insulin delivery ", Biomaterials. 2006, 27, 4498-4507.
52. Ferreira, L., Gil, M. H., Cabrita, A. M., Dordick, J. S. " Biocatalytic synthesis of highly ordered degradable dextran-based hydrogels ", Biomaterials. 2005, 26, 4707-4716.
53. Maire, M., Chaubet, F., Mary, P., Blanchat, C., Meunier, A., Logeart-Avramoglou, D. " Bovine BMP osteoinductive potential enhanced by functionalized dextran-derived hydrogels ", Biomaterials. 2005, 26, 5085-5092.
54. Maire, M., Logeart-Avramoglou, D., Degat, M. C., Chaubet, F. " Retention of transforming growth factor beta1 using functionalized dextran-based hydrogels ", Biomaterials. 2005, 26, 1771-1780.
55. Challa, R., Ahuja, A., Ali, J., Khar, R. K. " Cyclodextrins in drug delivery: An updated review ", AAPS PharmSciTech. 2005, 6, E329-357.
56. Kanwar, J. R., Long, B. M., Kanwar, R. K. " The use of cyclodextrins nanoparticles for oral delivery ", Curr. Med. Chem. 2011, 18, 2079-2085.
57. Li, J., Yang, C., Li, H., Wang, X., Goh, S. H., Ding, J. L., Wang, D. Y., Leong, K. W. " Cationic supramolecules composed of multiple oligoethylenimine-grafted β-cyclodextrins threaded on a polymer chain for efficient gene delivery ", Adv. Mater. 2006, 18, 2969-2974.
58. Brewster, M. E., Loftsson, T. " Cyclodextrins as pharmaceutical solubilizers ", Adv. Drug Deliv. Rev. 2007, 59, 645-666.
59. Irie, T., Uekama, K. " Cyclodextrins in peptide and protein delivery ", Adv. Drug Deliv. Rev. 1999, 36, 101-123.
60. Jerry, N., Anitha, Y., Sharma, C. P., Sony, P. " In vivo absorption studies of insulin from an oral delivery system ", Drug Deliv. 2001, 8, 19-23.
61. Li, J., Li, X., Ni, X., Wang, X., Li, H., Leong, K. W. " Self-assembled supramolecular hydrogels formed by biodegradable PEO-PHB-PEO triblock copolymers and alpha-cyclodextrin for controlled drug delivery ", Biomaterials. 2006, 27, 4132-4140.
62. Jessel, N., Oulad-Abdelghani, M., Meyer, F., Lavalle, P., Haikel, Y., Schaaf, P., Voegel, J. C. " Multiple and time-scheduled in situ DNA delivery mediated by beta-cyclodextrin embedded in a polyelectrolyte multilayer ", Proc. Natl. Acad. Sci. U.S.A. 2006, 103, 8618-8621.
63. Li, J., Loh, X. J. " Cyclodextrin-based supramolecular architectures: syntheses, structures, and applications for drug and gene delivery ", Adv. Drug Deliv. Rev. 2008, 60, 1000-1017.
64. Gombotz, W. R., Wee, S. F. " Protein release from alginate matrices ", Adv. Drug Deliv. Rev. 2012, 64, 194-205.
65. Woitiski, C. B., Sarmento, B., Carvalho, R. A., Neufeld, R. J., Veiga, F. " Facilitated nanoscale delivery of insulin across intestinal membrane models ", Int. J. Pharm. 2011, 412, 123-131.
66. Gu, F., Amsden, B., Neufeld, R. " Sustained delivery of vascular endothelial growth factor with alginate beads ", J. Control. Release. 2004, 96, 463-472.
67. Chen, S. C., Wu, Y. C., Mi, F. L., Lin, Y. H., Yu, L. C., Sung, H. W. " A novel pH-sensitive hydrogel composed of N, O-carboxymethyl chitosan and alginate cross-linked by genipin for protein drug delivery ", J. Control. Release. 2004, 96, 285-300.
68. Keshaw, H., Forbes, A., Day, R. M. " Release of angiogenic growth factors from cells encapsulated in alginate beads with bioactive glass ", Biomaterials. 2005, 26, 4171-4179.
69. Dai, C., Wang, B., Zhao, H., Li, B., Wang, J. " Preparation and characterization of liposomes-in-alginate (LIA) for protein delivery system ", Colloids Surf. B Biointerfaces. 2006, 47, 205-210.
70. Ruvinov, E., Leor, J., Cohen, S. " The effects of controlled HGF delivery from an affinity-binding alginate biomaterial on angiogenesis and blood perfusion in a hindlimb ischemia model ", Biomaterials. 2010, 31, 4573-4582.
71. Liu, L., Fishman, M. L., Hicks, K. B., Kende, M. " Interaction of various pectin formulations with porcine colonic tissues ", Biomaterials. 2005, 26, 5907-5916.
72. Thirawong, N., Nunthanid, J., Puttipipatkhachorn, S., Sriamornsak, P. " Mucoadhesive properties of various pectins on gastrointestinal mucosa: an in vitro evaluation using texture analyzer ", Eur. J. Pharm. Biopharm. 2007, 67, 132-140.
73. Liu, L., Fishman, M. L., Hicks, K. B. " Pectin in controlled drug delivery: A review ", Cellulose. 2007, 14, 15-24.
74. Watts, P., Smith, A. " PecSys: In situ gelling system for optimised nasal drug delivery ", Expert Opin. Drug Deliv. 2009, 6, 543-552.
75. Morris, G. A., Kök, S. M., Harding, S. E., Adams, G. G. " Polysaccharide drug delivery systems based on pectin and chitosan ", Biotechnol. Genet. Eng. Rev. 2010, 27, 257-284.
76. Liu, L., Fishman, M. L., Kost, J., Hicks, K. B. " Pectin-based systems for colon-specific drug delivery via oral route ", Biomaterials. 2003, 24, 3333-3343.
77. Sriamornsak, P. " Application of pectin in oral drug delivery ", Expert Opin. Drug Deliv. 2011, 8, 1009-1023.
78. Munarin, F., Tanzi, M. C., Petrini, P. " Advances in biomedical applications of pectin gels ", Int. J. Biol. Macromol. 2012, 51, 681-689.
79. Maiti, S., Ray, S., Mandal, B., Sarkar, S., Sa, B. " Carboxymethyl xanthan microparticles as a carrier for protein delivery ", J. Microencapsul. 2007, 24, 743-756.
80. Shah, S. N., Asghar, S., Choudhry, M. A., Akash, M. S. H., ur Rehman, N., Baksh, S. " Formulation and evaluation of natural gum-based sustained release matrix tablets of flurbiprofen using response surface methodology ", Drug Dev. Ind. Pharm. 2009, 35, 1470-1478.
81. Akash, M. S. H., Iqbal, F., Raza, M., Rehman, K., Ahmed, S., Shahzad, Y., Shah, S. " Characterization of ethylcellulose and hydroxypropyl methylcellulose microspheres for controlled release of Flurbiprofen ", J. Pharm. Drug Deliv. Res. 2013, 2, doi: 10.4172/2325-9604.1000113.
82. Akash, M. S. H., Khan, I., Shah, S., Asghar, S., Massud, A., Qadir, M., Akbar, A. " Sustained release hydrophilic matrices based on xanthan gum and hydroxypropyl methylcellulose: Development, optimization, in vitro and in vivo evaluation ", J. App. Pharm. 2010, 4, 89-103.
83. Badwaik, H. R., Giri, T. K., Nakhate, K. T., Kashyap, P., Tripathi, D. K. " Xanthan gum and its derivatives as a potential bio-polymeric carrier for drug delivery system ", Curr. Drug Deliv. 2013, 10, 587-600.
84. Maiti, S., Ray, S., Sa, B. " Controlled delivery of bovine serum albumin from carboxymethyl xanthan microparticles ", Pharm. Dev. Technol. 2009, 14, 165-172.
85. Maiti, S., Ray, S., Sa, B. " Effect of formulation variables on entrapment efficiency and release characteristics of bovine serum albumin from carboxymethyl xanthan microparticles ", Polym. Adv. Technol. 2008, 19, 922-927.
86. Elzoghby, A. O., Samy, W. M., Elgindy, N. A. " Protein-based nanocarriers as promising drug and gene delivery systems ", J. Control. Release. 2012, 161, 38-49.
87. Kaul, G., Amiji, M. " Long-circulating poly(ethylene glycol)-modified gelatin nanoparticles for intracellular delivery ", Pharm. Res. 2002, 19, 1061-1067.
88. Kaul, G., Amiji, M. " Tumor-targeted gene delivery using poly(ethylene glycol)-modified gelatin nanoparticles: in vitro and in vivo studies ", Pharm. Res. 2005, 22, 951-961.
89. Romberg, B., Hennink, W. E., Storm, G. " Sheddable coatings for long-circulating nanoparticles ", Pharm. Res. 2008, 25, 55-71.
90. Winkler, S., Kaplan, D. L. " Molecular biology of spider silk ", J. Biotechnol. 2000, 74, 85-93.
91. Wenk, E., Merkle, H. P., Meinel, L. " Silk fibroin as a vehicle for drug delivery applications ", J. Control. Release. 2011, 150, 128-141.
92. Massodi, I., Bidwell, G. L., 3rd; Raucher, D. " Evaluation of cell penetrating peptides fused to elastin-like polypeptide for drug delivery ", J. Control. Release. 2005, 108, 396-408.
93. Numata, K., Hamasaki, J., Subramanian, B., Kaplan, D. L. " Gene delivery mediated by recombinant silk proteins containing cationic and cell binding motifs ", J. Control. Release. 2010, 146, 136-143.
94. Numata, K., Kaplan, D. L. " Silk-based delivery systems of bioactive molecules ", Adv. Drug Deliv. Rev. 2010, 62, 1497-1508.
95. Numata, K., Subramanian, B., Currie, H. A., Kaplan, D. L. " Bioengineered silk protein-based gene delivery systems ", Biomaterials. 2009, 30, 5775-5784.
96. Numata, K., Kaplan, D. L. " Silk-based gene carriers with cell membrane destabilizing peptides ", Biomacromolecules. 2010, 11, 3189-3195.
97. Akash, M. S. H., Rehman, K., Chen, S. " IL-1Ra and its delivery strategies: Inserting the association in perspective ", Pharm. Res. 2013, 30, 2951-2966.
98. Martino, M., Tamburro, A. M. " Chemical synthesis of cross-linked poly(KGGVG), an elastin-like biopolymer ", Biopolymers. 2001, 59, 29-37.
99. Martino, M., Coviello, A., Tamburro, A. M. " Synthesis and structural characterization of poly(LGGVG), an elastin-like polypeptide ", Int. J. Biol. Macromol. 2000, 27, 59-64.
100. Spezzacatena, C., Perri, T., Guantieri, V., Sandberg, L. B., Mitts, T. F., Tamburro, A. M. " Classical synthesis of and structural studies on a biologically active heptapeptide and a nonapeptide of bovine elastin ", Eur. J. Org. Chem. 2002, 2002, 95-103.
101. Chow, D., Nunalee, M. L., Lim, D. W., Simnick, A. J., Chilkoti, A. " Peptide-based biopolymers in biomedicine and biotechnology ", Mater. Sci. Eng. R. Rep. 2008, 62, 125-155.
102. Betre, H., Liu, W., Zalutsky, M. R., Chilkoti, A., Kraus, V. B., Setton, L. A. " A thermally responsive biopolymer for intra-articular drug delivery ", J. Control. Release. 2006, 115, 175-182.
103. Shamji, M. F., Betre, H., Kraus, V. B., Chen, J., Chilkoti, A., Pichika, R., Masuda, K., Setton, L. A. " Development and characterization of a fusion protein between thermally responsive elastin-like polypeptide and interleukin-1 receptor antagonist: Sustained release of a local antiinflammatory therapeutic ", Arthritis Rheum. 2007, 56, 3650-3661.
104. Kim, D. H., Smith, J. T., Chilkoti, A., Reichert, W. M. " The effect of covalently immobilized rhIL-1ra-ELP fusion protein on the inflammatory profile of LPS-stimulated human monocytes ", Biomaterials. 2007, 28, 3369-3377.
105. Christensen, T., Amiram, M., Dagher, S., Trabbic-Carlson, K., Shamji, M. F., Setton, L. A., Chilkoti, A. " Fusion order controls expression level and activity of elastin-like polypeptide fusion proteins ", Protein Sci. 2009, 18, 1377-1387.
106. Klouda, L., Mikos, A. G. " Thermoresponsive hydrogels in biomedical applications ", Eur. J. Pharm. Biopharm. 2008, 68, 34-45.
107. Yang, H., Kao, W. J. " Thermoresponsive gelatin/monomethoxy poly(ethylene glycol)-poly(D, L-lactide) hydrogels: Formulation, characterization, and antibacterial drug delivery ", Pharm. Res. 2006, 23, 205-214.
108. Joly-Duhamel, C., Hellio, D., Djabourov, M. " All gelatin networks: 1. Biodiversity and physical chemistry ", Langmuir. 2002, 18, 7208-7217.
109. Gil, E. S., Frankowski, D. J., Spontak, R. J., Hudson, S. M. " Swelling behavior and morphological evolution of mixed gelatin/silk fibroin hydrogels ", Biomacromolecules. 2005, 6, 3079-3087.
110. Ohya, S., Matsuda, T. " Poly (N-isopropylacrylamide)(PNIPAM)-grafted gelatin as thermoresponsive three-dimensional artificial extracellular matrix: Molecular and formulation parameters vs. cell proliferation potential ", J. Biomater. Sci. Polym. Ed. 2005, 16, 809-827.
111. Magadala, P., Amiji, M. " Epidermal growth factor receptor-targeted gelatin-based engineered nanocarriers for DNA delivery and transfection in human pancreatic cancer cells ", AAPS J. 2008, 10, 565-576.
112. Elzoghby, A. O. " Gelatin-based nanoparticles as drug and gene delivery systems: reviewing three decades of research ", J. Control. Release. 2013, 172, 1075-1091.
113. Xu, J., Singh, A., Amiji, M. M. " Redox-responsive targeted gelatin nanoparticles for delivery of combination wt-p53 expressing plasmid DNA and gemcitabine in the treatment of pancreatic cancer ", BMC Cancer. 2014, 14, 75.
114. Lee, C. H., Singla, A., Lee, Y. " Biomedical applications of collagen ", Int. J. Pharm. 2001, 221, 1-22.
115. Maeda, M., Kadota, K., Kajihara, M., Sano, A., Fujioka, K. " Sustained release of human growth hormone (hGH) from collagen film and evaluation of effect on wound healing in db/db mice ", J. Control. Release. 2001, 77, 261-272.
116. Jahanshahi, M., Babaei, Z. " Protein nanoparticle: A unique system as drug delivery vehicles ", Afr. J. Biotechnol. 2008, 7, 4926-4934.
117. Kratz, F. " Albumin as a drug carrier: Design of prodrugs, drug conjugates and nanoparticles ", J. Control. Release. 2008, 132, 171-183.
118. Elzoghby, A. O., Samy, W. M., Elgindy, N. A. " Albumin-based nanoparticles as potential controlled release drug delivery systems ", J. Control. Release. 2012, 157, 168-182.
119. Elsadek, B., Kratz, F. " Impact of albumin on drug delivery: New applications on the horizon ", J. Control. Release. 2012, 157, 4-28.
120. Yu, S., Yao, P., Jiang, M., Zhang, G. " Nanogels prepared by self-assembly of oppositely charged globular proteins ", Biopolymers. 2006, 83, 148-158.
121. Dreis, S., Rothweiler, F., Michaelis, M., Cinatl, J., Jr., Kreuter, J., Langer, K. " Preparation, characterisation and maintenance of drug efficacy of doxorubicin-loaded human serum albumin (HSA) nanoparticles ", Int. J. Pharm. 2007, 341, 207-214.
122. Minko, T. " Drug targeting to the colon with lectins and neoglycoconjugates ", Adv. Drug Deliv. Rev. 2004, 56, 491-509.
123. Lehr, C. M. " Lectin-mediated drug delivery: The second generation of bioadhesives ", J. Control. Release. 2000, 65, 19-29.
124. Gabor, F., Schwarzbauer, A., Wirth, M. " Lectin-mediated drug delivery: Binding and uptake of BSA-WGA conjugates using the Caco-2 model ", Int. J. Pharm. 2002, 237, 227-239.
125. Harris, J. M., Chess, R. B. " Effect of pegylation on pharmaceuticals ", Nat. Rev. Drug Discov. 2003, 2, 214-221.
126. Fishburn, C. S. " The pharmacology of PEGylation: Balancing PD with PK to generate novel therapeutics ", J. Pharm. Sci. 2008, 97, 4167-4183.
127. Bansal, R., Post, E., Proost, J. H., de Jager-Krikken, A., Poelstra, K., Prakash, J. " PEGylation improves pharmacokinetic profile, liver uptake and efficacy of Interferon gamma in liver fibrosis ", J. Control. Release. 2011, 154, 233-240.
128. Palm, T., Esfandiary, R., Gandhi, R. " The effect of PEGylation on the stability of small therapeutic proteins ", Pharm. Dev. Technol. 2011, 16, 441-448.
129. Pfister, D., Morbidelli, M. " Process for protein PEGylation ", J Control Release. 2014, 180C, 134-149.
130. Calceti, P., Salmaso, S., Walker, G., Bernkop-Schnurch, A. " Development and in vivo evaluation of an oral insulin-PEG delivery system ", Eur. J. Pharm. Sci. 2004, 22, 315-323.
131. Hinds, K. D., Campbell, K. M., Holland, K. M., Lewis, D. H., Piche, C. A., Schmidt, P. G. " PEGylated insulin in PLGA microparticles: In vivo and in vitro analysis ", J. Control. Release. 2005, 104, 447-460.
132. Dou, H., Zhang, M., Zhang, Y., Yin, C. " Synthesis and purification of mono-PEGylated insulin ", Chem. Biol. Drug Des. 2007, 69, 132-138.
133. Gehrig, S. M., van der Poel, C., Hoeflich, A., Naim, T., Lynch, G. S., Metzger, F. " Therapeutic potential of PEGylated insulin-like growth factor I for skeletal muscle disease evaluated in two murine models of muscular dystrophy ", Growth Horm. IGF Res. 2012, 22, 69-75.
134. Freitas Dda, S., Spencer, P. J., Vassao, R. C., Abrahao-Neto, J. " Biochemical and biopharmaceutical properties of PEGylated uricase ", Int. J. Pharm. 2010, 387, 215-222.
135. Batra, J., Robinson, J., Mehner, C., Hockla, A., Miller, E., Radisky, D. C., Radisky, E. S. " PEGylation extends circulation half-life while preserving in vitro and in vivo activity of tissue inhibitor of metalloproteinases-1 (TIMP-1) ", PLoS One. 2012, 7, e50028.
136. da Silva Freitas, D., Mero, A., Pasut, G. " Chemical and enzymatic site specific PEGylation of hGH ", Bioconjug. Chem. 2013, 24, 456-463.
137. Qiu, H., Boudanova, E., Park, A., Bird, J. J., Honey, D. M., Zarazinski, C., Greene, B., Kingsbury, J. S., Boucher, S., Pollock, J., McPherson, J. M., Pan, C. Q. " Site-specific PEGylation of human thyroid stimulating hormone to prolong duration of action ", Bioconjug. Chem. 2013, 24, 408-418.
138. Xue, X., Li, D., Yu, J., Ma, G., Su, Z., Hu, T. " Phenyl linker-induced dense PEG conformation improves the efficacy of C-terminally monoPEGylated staphylokinase ", Biomacromolecules. 2013, 14, 331-341.
139. Lee, S., Youn, Y. S., Lee, S. H., Byun, Y., Lee, K. C. " PEGylated glucagon-like peptide-1 displays preserved effects on insulin release in isolated pancreatic islets and improved biological activity in db/db mice ", Diabetologia. 2006, 49, 1608-1611.
140. Lee, S. H., Lee, S., Youn, Y. S., Na, D. H., Chae, S. Y., Byun, Y., Lee, K. C. " Synthesis, characterization, and pharmacokinetic studies of PEGylated glucagon-like peptide-1 ", Bioconjug. Chem. 2005, 16, 377-382.
141. Youn, Y. S., Chae, S. Y., Lee, S., Jeon, J. E., Shin, H. G., Lee, K. C. " Evaluation of therapeutic potentials of site-specific PEGylated glucagon-like peptide-1 isomers as a type 2 anti-diabetic treatment: Insulinotropic activity, glucose-stabilizing capability, and proteolytic stability ", Biochem. Pharmacol. 2007, 73, 84-93.
142. Youn, Y. S., Jeon, J. E., Chae, S. Y., Lee, S., Lee, K. C. " PEGylation improves the hypoglycaemic efficacy of intranasally administered glucagon-like peptide-1 in type 2 diabetic db/db mice ", Diabetes Obes. Metab. 2008, 10, 343-346.
143. Chae, S. Y., Jin, C. H., Shin, H. J., Youn, Y. S., Lee, S., Lee, K. C. " Preparation, characterization, and application of biotinylated and biotin-PEGylated glucagon-like peptide-1 analogues for enhanced oral delivery ", Bioconjug. Chem. 2008, 19, 334-341.
144. Gong, N., Ma, A. N., Zhang, L. J., Luo, X. S., Zhang, Y. H., Xu, M., Wang, Y. X. " Site-specific PEGylation of exenatide analogues markedly improved their glucoregulatory activity ", Br. J. Pharmacol. 2011, 163, 399-412.
145. Gong, C., Qi, T., Wei, X., Qu, Y., Wu, Q., Luo, F., Qian, Z. " Thermosensitive polymeric hydrogels as drug delivery systems ", Curr. Med. Chem. 2013, 20, 79-94.
146. Riley, T., Stolnik, S., Heald, C., Xiong, C., Garnett, M., Illum, L., Davis, S., Purkiss, S., Barlow, R., Gellert, P. " Physicochemical evaluation of nanoparticles assembled from poly (lactic acid)-poly (ethylene glycol)(PLA-PEG) block copolymers as drug delivery vehicles ", Langmuir. 2001, 17, 3168-3174.
147. Vila, A., Sanchez, A., Evora, C., Soriano, I., Vila Jato, J. L., Alonso, M. J. " PEG-PLA nanoparticles as carriers for nasal vaccine delivery ", J Aerosol Med. 2004, 17, 174-185.
148. Vila, A., Sanchez, A., Pérez, C., Alonso, M. J. " PLA-PEG nanospheres: New carriers for transmucosal delivery of proteins and plasmid DNA ", Polym. Adv. Technol. 2002, 13, 851-858.
149. Vila, A., Sanchez, A., Evora, C., Soriano, I., McCallion, O., Alonso, M. J. " PLA-PEG particles as nasal protein carriers: The influence of the particle size ", Int. J. Pharm. 2005, 292, 43-52.
150. Mondrinos, M. J., Dembzynski, R., Lu, L., Byrapogu, V. K., Wootton, D. M., Lelkes, P. I., Zhou, J. " Porogen-based solid freeform fabrication of polycaprolactone-calcium phosphate scaffolds for tissue engineering ", Biomaterials. 2006, 27, 4399-4408.
151. Seregin V. V., Coffer, J. L. Biomineralization of calcium disilicide in porous polycaprolactone scaffolds ", Biomaterials. 2006, 27 4745-4754.
152. Chen, D., Bei, J., Wang, S. " Polycaprolactone microparticles and their biodegradation ", Polym. Degrad. Stab. 2000, 67, 455-459.
153. Moon, H. T., Lee, Y. K., Han, J. K., Byun, Y. " Improved blood compatibility by sustained release of heparin-deoxycholic acid conjugates in a PCL-PEG multiblock copolymer matrix ", J. Biomater. Sci. Polym. Ed. 2002, 13, 817-828.
154. Huang, M. H., Li, S., Hutmacher, D. W., Schantz, J. T., Vacanti, C. A., Braud, C., Vert, M. " Degradation and cell culture studies on block copolymers prepared by ring opening polymerization of epsilon-caprolactone in the presence of poly(ethylene glycol) ", J. Biomed. Mater. Res. A. 2004, 69, 417-427.
155. Hwang, M. J., Suh, J. M., Bae, Y. H., Kim, S. W., Jeong, B. " Caprolactonic poloxamer analog: PEG-PCL-PEG ", Biomacromolecules. 2005, 6, 885-890.
156. Gong, C. Y., Wu, Q. J., Dong, P. W., Shi, S., Fu, S. Z., Guo, G., Hu, H. Z., Zhao, X., Wei, Y. Q., Qian, Z. Y. " Acute toxicity evaluation of biodegradable in situ gel-forming controlled drug delivery system based on thermosensitive PEG-PCL-PEG hydrogel ", J. Biomed. Mater. Res. B Appl. Biomater. 2009, 91, 26-36.
157. Gong, C. Y., Dong, P. W., Shi, S., Fu, S. Z., Yang, J. L., Guo, G., Zhao, X., Wei, Y. Q., Qian, Z. Y. " Thermosensitive PEG-PCL-PEG hydrogel controlled drug delivery system: sol-gel-sol transition and in vitro drug release study ", J. Pharm. Sci. 2009, 98, 3707-3717.
158. Gong, C., Shi, S., Dong, P., Kan, B., Gou, M., Wang, X., Li, X., Luo, F., Zhao, X., Wei, Y., Qian, Z. " Synthesis and characterization of PEG-PCL-PEG thermosensitive hydrogel ", Int. J. Pharm. 2009, 365, 89-99.
159. Gong, C., Qian, Z., Liu, C., Huang, M., Gu, Y., Wen, Y., Kan, B., Wang, K., Dai, M., Li, X. " A thermosensitive hydrogel based on biodegradable amphiphilic poly (ethylene glycol)-polycaprolactone-poly (ethylene glycol) block copolymers ", Smart Mater. struct. 2007, 16, 927-933.
160. Huynh, D. P., Nguyen, M. K., Pi, B. S., Kim, M. S., Chae, S. Y., Lee, K. C., Kim, B. S., Kim, S. W., Lee, D. S. " Functionalized injectable hydrogels for controlled insulin delivery ", Biomaterials. 2008, 29, 2527-2534.
161. Gong, C. Y., Shi, S., Peng, X. Y., Kan, B., Yang, L., Huang, M. J., Luo, F., Zhao, X., Wei, Y. Q., Qian, Z. Y. " Biodegradable thermosensitive injectable PEG-PCL-PEG hydrogel for bFGF antigen delivery to improve humoral immunity ", Growth Factors. 2009, 27, 377-383.
162. Wu, Q. J., Zhu, X. C., Xiao, X., Wang, P., Xiong da, K., Gong, C. Y., Wang, Y. S., Yang, L., Wei, Y. Q. " A novel vaccine delivery system: Biodegradable nanoparticles in thermosensitive hydrogel ", Growth Factors. 2011, 29, 290-297.
163. Shi, H.-S., Gong, C.-Y., Zhang, H.-L., Wang, Y.-S., Zhang, J., Luo, Z.-C., Qian, Z.-Y., Wei, Y.-Q., Yang, L. " Novel vaccine adjuvant LPS-Hydrogel for truncated basic fibroblast growth factor to induce antitumor immunity ", Carbohydr. Polym. 2012, 89, 1101-1109.
164. Yang, Y. Y., Chung, T. S., Ng, N. P. " Morphology, drug distribution, and in vitro release profiles of biodegradable polymeric microspheres containing protein fabricated by double-emulsion solvent extraction/evaporation method ", Biomaterials. 2001, 22, 231-241.
165. Makadia, H. K., Siegel, S. J. " Poly Lactic-co-Glycolic Acid (PLGA) as biodegradable controlled drug delivery carrier ", Polymers (Basel). 2011, 3, 1377-1397.
166. Diwan, M., Park, T. G. " Stabilization of recombinant interferon-alpha by pegylation for encapsulation in PLGA microspheres ", Int. J. Pharm. 2003, 252, 111-122.
167. Zheng, C. H., Liang, W. Q., Yu, H. Y., Chen, H. L. " Evaluation of different methods to determine the loading of proteins in PLGA microspheres ", Pharmazie. 2004, 59, 232-233.
168. Bouissou, C., Rouse, J. J., Price, R., van der Walle, C. F. " The influence of surfactant on PLGA microsphere glass transition and water sorption: Remodeling the surface morphology to attenuate the burst release ", Pharm. Res. 2006, 23, 1295-1305.
169. Kang, J., Schwendeman, S. P. " Comparison of the effects of Mg(OH)2 and sucrose on the stability of bovine serum albumin encapsulated in injectable poly(D, L-lactide-co-glycolide) implants ", Biomaterials. 2002, 23, 239-245.
170. Zheng, C. H., Gao, J. Q., Zhang, Y. P., Liang, W. Q. " A protein delivery system: biodegradable alginate-chitosan-poly(lactic-co-glycolic acid) composite microspheres ", Biochem. Biophys. Res. Commun. 2004, 323, 1321-1327.
171. Li, Y., Pei, Y., Zhang, X., Gu, Z., Zhou, Z., Yuan, W., Zhou, J., Zhu, J., Gao, X. " PEGylated PLGA nanoparticles as protein carriers: Synthesis, preparation and biodistribution in rats ", J. Control. Release. 2001, 71, 203-211.
172. Cheng, J., Teply, B. A., Sherifi, I., Sung, J., Luther, G., Gu, F. X., Levy-Nissenbaum, E., Radovic-Moreno, A. F., Langer, R., Farokhzad, O. C. " Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery ", Biomaterials. 2007, 28, 869-876.
173. Ghahremankhani, A. A., Dorkoosh, F., Dinarvand, R. " PLGA-PEG-PLGA tri-block copolymers as an in-situ gel forming system for calcitonin delivery ", Polym. Bull. 2007, 59, 637-646.
174. Jeong, B., Bae, Y. H., Kim, S. W. " In situ gelation of PEG-PLGA-PEG triblock copolymer aqueous solutions and degradation thereof ", J. Biomed. Mater. Res. 2000, 50, 171-177.
175. Jeong, B., Bae, Y. H., Kim, S. W. " Drug release from biodegradable injectable thermosensitive hydrogel of PEG-PLGA-PEG triblock copolymers ", J. Control. Release. 2000, 63, 155-163.
176. Jeong, B., Choi, Y. K., Bae, Y. H., Zentner, G., Kim, S. W. " New biodegradable polymers for injectable drug delivery systems ", J. Control. Release. 1999, 62, 109-114.
177. Jeong, B., Kim, S. W., Bae, Y. H. " Thermosensitive sol-gel reversible hydrogels ", Adv. Drug Deliv. Rev. 2002, 54, 37-51.
178. Yoo, H. S., Park, T. G. " Biodegradable polymeric micelles composed of doxorubicin conjugated PLGA-PEG block copolymer ", J. Control. Release. 2001, 70, 63-70.
179. Zentner, G. M., Rathi, R., Shih, C., McRea, J. C., Seo, M. H., Oh, H., Rhee, B. G., Mestecky, J., Moldoveanu, Z., Morgan, M., Weitman, S. " Biodegradable block copolymers for delivery of proteins and water-insoluble drugs ", J. Control. Release. 2001, 72, 203-215.
180. Kim, Y. J., Choi, S., Koh, J. J., Lee, M., Ko, K. S., Kim, S. W. " Controlled release of insulin from injectable biodegradable triblock copolymer ", Pharm. Res. 2001, 18, 548-550.
181. Lee, P. Y., Li, Z., Huang, L. " Thermosensitive hydrogel as a Tgf-beta1 gene delivery vehicle enhances diabetic wound healing ", Pharm. Res. 2003, 20, 1995-2000.
182. Chang, C. W., Choi, D., Kim, W. J., Yockman, J. W., Christensen, L. V., Kim, Y. H., Kim, S. W. " Non-ionic amphiphilic biodegradable PEG-PLGA-PEG copolymer enhances gene delivery efficiency in rat skeletal muscle ", J. Control. Release. 2007, 118, 245-253.
183. Yin, X., Hoffman, A. S., Stayton, P. S. " Poly(N-isopropylacrylamide-co-propylacrylic acid) copolymers that respond sharply to temperature and pH ", Biomacromolecules. 2006, 7, 1381-1385.
184. Coughlan, D. C., Quilty, F. P., Corrigan, O. I. " Effect of drug physicochemical properties on swelling/deswelling kinetics and pulsatile drug release from thermoresponsive poly(N-isopropylacrylamide) hydrogels ", J. Control. Release. 2004, 98, 97-114.
185. Liu, Y. Y., Shao, Y. H., Lu, J. " Preparation, properties and controlled release behaviors of pH-induced thermosensitive amphiphilic gels ", Biomaterials. 2006, 27, 4016-4024.
186. Nakayama, M., Okano, T., Miyazaki, T., Kohori, F., Sakai, K., Yokoyama, M. " Molecular design of biodegradable polymeric micelles for temperature-responsive drug release ", J. Control. Release. 2006, 115, 46-56.
187. Uludag, H., Norrie, B., Kousinioris, N., Gao, T. " Engineering temperature-sensitive poly(N-isopropylacrylamide) polymers as carriers of therapeutic proteins ", Biotechnol. Bioeng. 2001, 73, 510-521.
188. Jeong, B., Bae, Y. H., Lee, D. S., Kim, S. W. " Biodegradable block copolymers as injectable drug-delivery systems ", Nature. 1997, 388, 860-862.
189. Bromberg, L., Levin, G. " Poly(amino acid)-b-poly(N, N-diethylacrylamide)-b-poly(amino acid) conjugates of well-defined structure ", Bioconjug. Chem. 1998, 9, 40-49.
190. Shubhra, Q. T., Tóth, J., Gyenis, J., Feczkó, T. " Poloxamers for surface modification of hydrophobic drug carriers and their effects on drug delivery ", Polym. Rev. 2014, 54, 112-138.
191. Moulay, S. " Dopa/catechol-tethered polymers: Bioadhesives and biomimetic adhesive materials ", Polym. Rev. 2014, 54, 436-513.
192. Ahn, J. S., Suh, J. M., Lee, M., Jeong, B. " Slow eroding biodegradable multiblock poloxamer copolymers ", Polym. Int. 2005, 54, 842-847.
193. Yu, L., Zhang, Z., Zhang, H., Ding, J. " Biodegradability and biocompatibility of thermoreversible hydrogels formed from mixing a sol and a precipitate of block copolymers in water ", Biomacromolecules. 2010, 11, 2169-2178.
194. Ward, M. A., Georgiou, T. K. " Thermoresponsive polymers for biomedical applications ", Polymers. 2011, 3, 1215-1242.
195. Moreno, E., Schwartz, J., Larraneta, E., Nguewa, P. A., Sanmartin, C., Agueros, M., Irache, J. M., Espuelas, S. " Thermosensitive hydrogels of poly(methyl vinyl ether-co-maleic anhydride)-Pluronic→ F127 copolymers for controlled protein release ", Int. J. Pharm. 2014, 459, 1-9.
196. Sosnik, A., Cohn, D. " Ethoxysilane-capped PEO-PPO-PEO triblocks: a new family of reverse thermo-responsive polymers ", Biomaterials. 2004, 25, 2851-2858.
197. Cheaburu, C. N., Ciocoiu, O.-N., Staikos, G., Vasile, C. " Thermoresponsive sodium alginate-g-poly(N-isopropylacrylamide) copolymers III. Solution properties ", J. Appl. Polym. Sci. 2013, 127, 3340-3348.
198. Kabanov, A. V., Alakhov, V. Y. " Pluronic block copolymers in drug delivery: from micellar nanocontainers to biological response modifiers ", Crit. Rev. Ther. Drug Carrier Syst. 2002, 19, 1-72.
199. Sosnik, A., Sefton, M. V. " Semi-synthetic collagen/poloxamine matrices for tissue engineering ", Biomaterials. 2005, 26, 7425-7435.
200. Akash, M. S. H., Rehman, K., Sun, H., Chen, S. " Assessment of release kinetics, stability and polymer interaction of poloxamer 407-based thermosensitive gel of interleukin-1 receptor antagonist ", Pharm. Dev. Technol. 2014, 19, 278-284.
201. Akash, M. S. H., Rehman, K., Li, N., Gao, J.-Q., Sun, H., Chen, S. " Sustained delivery of IL-1Ra from pluronic F127-based thermosensitive gel prolongs its therapeutic potentials ", Pharm. Res. 2012, 29, 3475-3485.
202. Batrakova, E. V., Li, S., Li, Y., Alakhov, V. Y., Elmquist, W. F., Kabanov, A. V. " Distribution kinetics of a micelle-forming block copolymer Pluronic P85 ", J. Control. Release. 2004, 100, 389-397.
203. Akash, M. S. H., Rehman, K., Chen, S. " Role of inflammatory mechanisms in pathogenesis of type 2 diabetes mellitus ", J. Cell. Biochem. 2013, 114, 525-531.
204. Akash, M. S. H., Shen, Q., Rehman, K., Chen, S. " Interleukin-1 receptor antagonist: a new therapy for type 2 diabetes mellitus ", J. Pharm. Sci. 2012, 101, 1647-1658.
205. Akash, M. S. H., Rehman, K., Chen, S. " Effects of coffee on type 2 diabetes mellitus ", Nutrition. 2014, 30, 755-763.
206. Akash, M. S. H., Rehman, K., Chen, S. " Spice plant Allium cepa: dietary supplement for treatment of type 2 diabetes mellitus ", Nutrition. 2014, 30, 1128-1137.
207. Ehses, J. A., Lacraz, G., Giroix, M. H., Schmidlin, F., Coulaud, J., Kassis, N., Irminger, J. C., Kergoat, M., Portha, B., Homo-Delarche, F., Donath, M. Y. " IL-1 antagonism reduces hyperglycemia and tissue inflammation in the type 2 diabetic GK rat ", Proc. Natl. Acad. Sci. U. S. A. 2009, 106, 13998-14003.
208. Akash, M. S. H., Rehman, K., Sun, H., Chen, S. " Interleukin-1 receptor antagonist improves normoglycemia and insulin sensitivity in diabetic Goto-Kakizaki-rats ", Eur. J. Pharmacol. 2013, 701, 87-95.
209. Akash, M. S. H., Rehman, K., Sun, H., Chen, S. " Sustained delivery of IL-1Ra from PF127-gel reduces hyperglycemia in diabetic GK-rats ", PLoS One. 2013, 8, e55925.
210. Akash, M. S. H., Rehman, K., Chen, S. " Pluronic F127-based thermosensitive gels for delivery of therapeutic proteins and peptides ", Polym. Rev. 2014, 54, 573-597.
211. Wang, P. L., Johnston, T. P. " Sustained-release interleukin-2 following intramuscular injection in rats ", Int. J. Pharm. 1995, 113, 73-81.
212. Liu, Y., Lu, W. L., Wang, J. C., Zhang, X., Zhang, H., Wang, X. Q., Zhou, T. Y., Zhang, Q. " Controlled delivery of recombinant hirudin based on thermo-sensitive Pluronic F127 hydrogel for subcutaneous administration: In vitro and in vivo characterization ", J. Control. Release. 2007, 117, 387-395.
213. Barichello, J. M., Morishita, M., Takayama, K., Nagai, T. " Absorption of insulin from pluronic F-127 gels following subcutaneous administration in rats ", Int. J. Pharm. 1999, 184, 189-198.
214. Wang, Y., Gao, J.-Q., Li, F., Sang-Hon, R., Liang, W.-Q. " Triblock copolymer Pluronic→ F127 sustains insulin release and reduces initial burst of microspheres: In vitro and in vivo study ", Colloid. Polym. Sci. 2006, 285, 233-238.
215. Nasir, F., Iqbal, Z., Khan, A., Khan, J. A., Khan, A., Khuda, F., Zakir, S., Yousaf, N., Khan, I., Shah, Y., Khan, M. I., Shahbaz, N. " Development and evaluation of pluronic-and methylcellulose-based thermoreversible drug delivery system for insulin ", Drug Dev. Ind. Pharm. 2014, 40, 1503-1508.
216. Barichello, J. M., Morishita, M., Takayama, K., Chiba, Y., Tokiwa, S., Nagai, T. " Enhanced rectal absorption of insulin-loaded Pluronic F-127 gels containing unsaturated fatty acids ", Int. J. Pharm. 1999, 183, 125-132.
217. Morishita, M., Barichello, J. M., Takayama, K., Chiba, Y., Tokiwa, S., Nagai, T. " Pluronic F-127 gels incorporating highly purified unsaturated fatty acids for buccal delivery of insulin ", Int. J. Pharm. 2001, 212, 289-293.
218. Das, N., Madan, P., Lin, S. " Development and in vitro evaluation of insulin-loaded buccal Pluronic F-127 gels ", Pharm. Dev. Technol. 2010, 15, 192-208.
219. Das, N., Madan, P., Lin, S. " Statistical optimization of insulin-loaded Pluronic F-127 gels for buccal delivery of basal insulin ", Pharm. Dev. Technol. 2012, 17, 363-374.
220. Pillai, O., Panchagnula, R. " Transdermal delivery of insulin from poloxamer gel: ex vivo and in vivo skin permeation studies in rat using iontophoresis and chemical enhancers ", J. Control. Release. 2003, 89, 127-140.
221. Wenzel, J. G., Balaji, K. S., Koushik, K., Navarre, C., Duran, S. H., Rahe, C. H., Kompella, U. B. " Pluronic F127 gel formulations of deslorelin and GnRH reduce drug degradation and sustain drug release and effect in cattle ", J. Control. Release. 2002, 85, 51-59.
222. Choi, J. S., Yoo, H. S. " Pluronic/chitosan hydrogels containing epidermal growth factor with wound-adhesive and photo-crosslinkable properties ", J. Biomed. Mater. Res. A. 2010, 95, 564-573.
223. Katakam, M., Ravis, W. R., Banga, A. K. " Controlled release of human growth hormone in rats following parenteral administration of poloxamer gels ", J. Control. Release 1997, 49, 21-26.
224. Katakam, M., Ravis, W. R., Golden, D. L., Banga, A. K. " Controlled release of human growth hormone following subcutaneous administration in dogs ", Int. J. Pharm. 1997, 152, 53-58.
225. Chung, H. J., Lee, Y., Park, T. G. " Thermo-sensitive and biodegradable hydrogels based on stereocomplexed Pluronic multi-block copolymers for controlled protein delivery ", J. Control. Release. 2008, 127, 22-30.
226. Kim, M. R., Park, T. G. " Temperature-responsive and degradable hyaluronic acid/Pluronic composite hydrogels for controlled release of human growth hormone ", J. Control. Release. 2002, 80, 69-77.
227. Strappe, P. M., Hampton, D. W., Cachon-Gonzalez, B., Fawcett, J. W., Lever, A. " Delivery of a lentiviral vector in a Pluronic F127 gel to cells of the central nervous system ", Eur. J. Pharm. Biopharm. 2005, 61, 126-133.
228. Lemieux, P., Guerin, N., Paradis, G., Proulx, R., Chistyakova, L., Kabanov, A., Alakhov, V. " A combination of poloxamers increases gene expression of plasmid DNA in skeletal muscle ", Gene Ther. 2000, 7, 986-991.
229. Chun, K. W., Lee, J. B., Kim, S. H., Park, T. G. " Controlled release of plasmid DNA from photo-cross-linked pluronic hydrogels ", Biomaterials. 2005, 26, 3319-3326.
230. Kustiawan, I., Derksen, N. I., Rispens, T. " Preventing adsorption of immunoglobulin G to solid surfaces using poloxamer 407 eliminates artifactual stimulation of neutrophils ", J. Immunol. Methods. 2013, 392, 49-56.
231. Todoroff, J., Ucakar, B., Inglese, M., Vandermarliere, S., Fillee, C., Renauld, J. C., Huygen, K., Vanbever, R. " Targeting the deep lungs, Poloxamer 407 and a CpG oligonucleotide optimize immune responses to Mycobacterium tuberculosis antigen 85A following pulmonary delivery ", Eur. J. Pharm. Biopharm. 2013, 84, 40-48.
232. Westerink, M. A., Smithson, S. L., Srivastava, N., Blonder, J., Coeshott, C., Rosenthal, G. J. " ProJuvant (Pluronic F127/chitosan) enhances the immune response to intranasally administered tetanus toxoid ", Vaccine. 2001, 20, 711-723.
233. Kang, M. L., Jiang, H. L., Kang, S. G., Guo, D. D., Lee, D. Y., Cho, C. S., Yoo, H. S. " Pluronic F127 enhances the effect as an adjuvant of chitosan microspheres in the intranasal delivery of Bordetella bronchiseptica antigens containing dermonecrotoxin ", Vaccine. 2007, 25, 4602-4610.
234. Coeshott, C. M., Smithson, S. L., Verderber, E., Samaniego, A., Blonder, J. M., Rosenthal, G. J., Westerink, M. A. " Pluronic F127-based systemic vaccine delivery systems ", Vaccine. 2004, 22, 2396-2405.
235. Pisal, S. S., Paradkar, A. R., Mahadik, K. R., Kadam, S. S. " Pluronic gels for nasal delivery of Vitamin B12. Part I: Preformulation study ", Int. J. Pharm. 2004, 270, 37-45.
236. Lee, S. Y., Tae, G. " Formulation and in vitro characterization of an in situ gelable, photo-polymerizable Pluronic hydrogel suitable for injection ", J. Control. Release. 2007, 119, 313-319.
237. Lee, S. Y., Tae, G., Kim, Y. H. " Thermal gellation and photo-polymerization of di-acrylated Pluronic F 127 ", J. Biomater. Sci. Polym. Ed. 2007, 18, 1335-1353.
238. Niu, G., Du, F., Song, L., Zhang, H., Yang, J., Cao, H., Zheng, Y., Yang, Z., Wang, G., Yang, H., Zhu, S. " Synthesis and characterization of reactive poloxamer 407s for biomedical applications ", J. Control. Release. 2009, 138, 49-56.
239. Hsu, S. H., Leu, Y. L., Hu, J. W., Fang, J. Y. " Physicochemical characterization and drug release of thermosensitive hydrogels composed of a hyaluronic acid/pluronic f127 graft ", Chem. Pharm. Bull. 2009, 57, 453-458.
240. Cohn, D., Lando, G., Sosnik, A., Garty, S., Levi, A. " PEO-PPO-PEO-based poly(ether ester urethane)s as degradable reverse thermo-responsive multiblock copolymers ", Biomaterials. 2006, 27, 1718-1727.
241. Liu, Y., Zhu, Y. Y., Wei, G., Lu, W. Y. " Effect of carrageenan on poloxamer-based in situ gel for vaginal use: Improved in vitro and in vivo sustained-release properties ", Eur. J. Pharm. Sci. 2009, 37, 306-312.
242. Kavimandan, N. J., Losi, E., Peppas, N. A. " Novel delivery system based on complexation hydrogels as delivery vehicles for insulin-transferrin conjugates ", Biomaterials. 2006, 27, 3846-3854.
243. Chalasani, K. B., Russell-Jones, G. J., Jain, A. K., Diwan, P. V., Jain, S. K. " Effective oral delivery of insulin in animal models using vitamin B12-coated dextran nanoparticles ", J. Control. Release. 2007, 122, 141-150.
244. Frandsen, J. L., Ghandehari, H. " Recombinant protein-based polymers for advanced drug delivery ", Chem. Soc. Rev. 2012, 41, 2696-2706.
245. Meyer, D. E., Chilkoti, A. " Genetically encoded synthesis of protein-based polymers with precisely specified molecular weight and sequence by recursive directional ligation: examples from the elastin-like polypeptide system ", Biomacromolecules. 2002, 3, 357-367.
246. Johnson, J. A., Lu, Y. Y., Van Deventer, J. A., Tirrell, D. A. " Residue-specific incorporation of non-canonical amino acids into proteins: Recent developments and applications ", Curr. Opin. Chem. Biol. 2010, 14, 774-780.
247. Haider, M., Megeed, Z., Ghandehari, H. " Genetically engineered polymers: status and prospects for controlled release ", J. Control. Release. 2004, 95, 1-26.
248. Kaufmann, D., Weberskirch, R. " Efficient synthesis of protein-drug conjugates using a functionalizable recombinant elastin-mimetic polypeptide ", Macromol. Biosci. 2006, 6, 952-958.
249. Chen, Y., Yuan, L., Zhou, L., Zhang, Z. H., Cao, W., Wu, Q. " Effect of cell-penetrating peptide-coated nanostructured lipid carriers on the oral absorption of tripterine ", Int. J. Nanomedicine. 2012, 7, 4581-4591.
250. Khafagy el, S., Morishita, M. " Oral biodrug delivery using cell-penetrating peptide ", Adv. Drug Deliv. Rev. 2012, 64, 531-539.
251. Koren, E., Torchilin, V. P. " Cell-penetrating peptides: Breaking through to the other side ", Trends Mol. Med. 2012, 18, 385-393.
252. Kamei, N., Morishita, M., Chiba, H., Kavimandan, N. J., Peppas, N. A., Takayama, K. " Complexation hydrogels for intestinal delivery of interferon beta and calcitonin ", J. Control. Release. 2009, 134, 98-102.
253. Kamei, N., Morishita, M., Eda, Y., Ida, N., Nishio, R., Takayama, K. " Usefulness of cell-penetrating peptides to improve intestinal insulin absorption ", J. Control. Release. 2008, 132, 21-25.
254. Kamei, N., Morishita, M., Takayama, K. " Importance of intermolecular interaction on the improvement of intestinal therapeutic peptide/protein absorption using cell-penetrating peptides ", J. Control. Release. 2009, 136, 179-186.
255. Khafagyel, S., Morishita, M., Kamei, N., Eda, Y., Ikeno, Y., Takayama, K. " Efficiency of cell-penetrating peptides on the nasal and intestinal absorption of therapeutic peptides and proteins ", Int. J. Pharm. 2009, 381, 49-55.
256. Trehin, R., Merkle, H. P. " Chances and pitfalls of cell penetrating peptides for cellular drug delivery ", Eur. J. Pharm. Biopharm. 2004, 58, 209-223.
257. Zorko, M., Langel, U. " Cell-penetrating peptides: Mechanism and kinetics of cargo delivery ", Adv. Drug Deliv. Rev. 2005, 57, 529-545.
258. Liang, J. F., Yang, V. C. " Insulin-cell penetrating peptide hybrids with improved intestinal absorption efficiency ", Biochem. Biophys. Res. Commun. 2005, 335, 734-738.
259. Torchilin, V. P., Levchenko, T. S., Rammohan, R., Volodina, N., Papahadjopoulos-Sternberg, B., D'Souza, G. G. " Cell transfection in vitro and in vivo with nontoxic TAT peptide-liposome-DNA complexes ", Proc. Natl. Acad. Sci. U. S. A. 2003, 100, 1972-1977.
260. Kleemann, E., Neu, M., Jekel, N., Fink, L., Schmehl, T., Gessler, T., Seeger, W., Kissel, T. " Nano-carriers for DNA delivery to the lung based upon a TAT-derived peptide covalently coupled to PEG-PEI ", J. Control. Release. 2005, 109, 299-316.
261. Morishita, M., Kamei, N., Ehara, J., Isowa, K., Takayama, K. " A novel approach using functional peptides for efficient intestinal absorption of insulin ", J. Control. Release. 2007, 118, 177-184.
262. Widera, A., Kim, K. J., Crandall, E. D., Shen, W. C. " Transcytosis of GCSF-transferrin across rat alveolar epithelial cell monolayers ", Pharm. Res. 2003, 20, 1231-1238.
263. Xia, C. Q., Wang, J., Shen, W. C. " Hypoglycemic effect of insulin-transferrin conjugate in streptozotocin-induced diabetic rats ", J. Pharmacol. Exp. Ther. 2000, 295, 594-600.
264. Amet, N., Wang, W., Shen, W. C. " Human growth hormone-transferrin fusion protein for oral delivery in hypophysectomized rats ", J. Control. Release. 2010, 141, 177-182.
265. Haider, M., Leung, V., Ferrari, F., Crissman, J., Powell, J., Cappello, J., Ghandehari, H. " Molecular engineering of silk-elastinlike polymers for matrix-mediated gene delivery: Biosynthesis and characterization ", Mol. Pharm. 2005, 2, 139-150.
266. Gustafson, J. A., Ghandehari, H. " Silk-elastinlike protein polymers for matrix-mediated cancer gene therapy ", Adv. Drug Deliv. Rev. 2010, 62, 1509-1523.
267. Gustafson, J. A., Price, R. A., Greish, K., Cappello, J., Ghandehari, H. " Silk-elastin-like hydrogel improves the safety of adenovirus-mediated gene-directed enzyme-prodrug therapy ", Mol. Pharm. 2010, 7, 1050-1056.
268. Hwang, D., Moolchandani, V., Dandu, R., Haider, M., Cappello, J., Ghandehari, H. " Influence of polymer structure and biodegradation on DNA release from silk-elastinlike protein polymer hydrogels ", Int. J. Pharm. 2009, 368, 215-219.
269. Gustafson, J., Greish, K., Frandsen, J., Cappello, J., Ghandehari, H. " Silk-elastinlike recombinant polymers for gene therapy of head and neck cancer: from molecular definition to controlled gene expression ", J. Control. Release. 2009, 140, 256-261.
270. Greish, K., Frandsen, J., Scharff, S., Gustafson, J., Cappello, J., Li, D., O'Malley, B. W., Jr., Ghandehari, H. " Silk-elastinlike protein polymers improve the efficacy of adenovirus thymidine kinase enzyme prodrug therapy of head and neck tumors ", J. Gene Med. 2010, 12, 572-579.
271. Dinerman, A. A., Cappello, J., Ghandehari, H., Hoag, S. W. " Solute diffusion in genetically engineered silk-elastinlike protein polymer hydrogels ", J. Control. Release. 2002, 82, 277-287.
272. Dinerman, A. A., Cappello, J., El-Sayed, M., Hoag, S. W., Ghandehari, H. " Influence of solute charge and hydrophobicity on partitioning and diffusion in a genetically engineered silk-elastin-like protein polymer hydrogel ", Macromol. Biosci. 2010, 10, 1235-1247.
273. Tae, G., Choi, W., Kim, J. Y., "Temperature-sensitive nano-carriers", Google Patents, 2009.
274. Alconcel, S. N., Baas, A. S., Maynard, H. D. " FDA-approved poly (ethylene glycol)-protein conjugate drugs ", Polym. Chem. 2011, 2, 1442-1448.
275. Domb, A. J., Kumar, N. Biodegradable Polymers in Clinical Use and Clinical Development; Wiley: NJ, 2011.
276. Vega-Villa, K. R., Takemoto, J. K., Yanez, J. A., Remsberg, C. M., Forrest, M. L., Davies, N. M. " Clinical toxicities of nanocarrier systems ", Adv Drug Deliv Rev. 2008, 60, 929-938.
277. Linkov, I., Satterstrom, F. K., Corey, L. M. " Nanotoxicology and nanomedicine: Making hard decisions ", Nanomedicine. 2008, 4, 167-171.
278. Aillon, K. L., Xie, Y., El-Gendy, N., Berkland, C. J., Forrest, M. L. " Effects of nanomaterial physicochemical properties on in vivo toxicity ", Adv. Drug Deliv. Rev. 2009, 61, 457-466.
279. Nel, A. E., Madler, L., Velegol, D., Xia, T., Hoek, E. M., Somasundaran, P., Klaessig, F., Castranova, V., Thompson, M. " Understanding biophysicochemical interactions at the nano-bio interface ", Nat. Mater. 2009, 8, 543-557.
280. Garnett, M. C., Kallinteri, P. " Nanomedicines and nanotoxicology: Some physiological principles ", Occup. Med. 2006, 56, 307-311.
281. Narayanan, D., Gopikrishna, J., Nair, S. V., Menon, D. In Proteins and Carbohydrates as Polymeric Nanodrug Delivery Systems: Formulation, Properties, and Toxicological Evaluation; Springer: NY, 2013, pp. 241-267.
282. Green, M. R., Manikhas, G. M., Orlov, S., Afanasyev, B., Makhson, A. M., Bhar, P., Hawkins, M. J. " Abraxane, a novel Cremophor-free, albumin-bound particle form of paclitaxel for the treatment of advanced non-small-cell lung cancer ", Ann. Oncol. 2006, 17, 1263-1268.
283. Mayer, A., Vadon, M., Rinner, B., Novak, A., Wintersteiger, R., Frohlich, E. " The role of nanoparticle size in hemocompatibility ", Toxicology. 2009, 258, 139-147.
284. Chou, T. C., Fu, E., Wu, C. J., Yeh, J. H. " Chitosan enhances platelet adhesion and aggregation ", Biochem. Biophys. Res. Commun. 2003, 302, 480-483.
285. Lee, D.-W., Powers, K., Baney, R. " Physicochemical properties and blood compatibility of acylated chitosan nanoparticles ", Carbohydr. Polym. 2004, 58, 371-377.
286. Prego, C., Torres, D., Fernandez-Megia, E., Novoa-Carballal, R., Quinoa, E., Alonso, M. J. " Chitosan-PEG nanocapsules as new carriers for oral peptide delivery: Effect of chitosan pegylation degree ", J. Control. Release. 2006, 111, 299-308.
287. Sagnella, S., Mai-Ngam, K. " Chitosan based surfactant polymers designed to improve blood compatibility on biomaterials ", Colloids Surf. B Biointerfaces. 2005, 42, 147-155.
288. Mao, C., Qiu, Y., Sang, H., Mei, H., Zhu, A., Shen, J., Lin, S. " Various approaches to modify biomaterial surfaces for improving hemocompatibility ", Adv. Colloid. Interface Sci. 2004, 110, 5-17.